EA200801847A1 - ПЕПТИДНОЕ ИНГИБИРОВАНИЕ ВЗАИМОДЕЙСТВИЯ caPCNA ПРИ РАКЕ - Google Patents
ПЕПТИДНОЕ ИНГИБИРОВАНИЕ ВЗАИМОДЕЙСТВИЯ caPCNA ПРИ РАКЕInfo
- Publication number
- EA200801847A1 EA200801847A1 EA200801847A EA200801847A EA200801847A1 EA 200801847 A1 EA200801847 A1 EA 200801847A1 EA 200801847 A EA200801847 A EA 200801847A EA 200801847 A EA200801847 A EA 200801847A EA 200801847 A1 EA200801847 A1 EA 200801847A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- cancer
- capcna
- peptide inhibition
- interaction
- capcna interaction
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74331306P | 2006-02-17 | 2006-02-17 | |
| PCT/US2007/062335 WO2007098415A2 (en) | 2006-02-17 | 2007-02-16 | Peptide based inhibition of capcna protein-protein interactions in cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA200801847A1 true EA200801847A1 (ru) | 2009-02-27 |
Family
ID=38235155
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200801847A EA200801847A1 (ru) | 2006-02-17 | 2007-02-16 | ПЕПТИДНОЕ ИНГИБИРОВАНИЕ ВЗАИМОДЕЙСТВИЯ caPCNA ПРИ РАКЕ |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US8653039B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1989225A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2009527498A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101384618A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2007217037A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0707948A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2638866C (cg-RX-API-DMAC7.html) |
| EA (1) | EA200801847A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007098415A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA200801847A1 (ru) * | 2006-02-17 | 2009-02-27 | Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн | ПЕПТИДНОЕ ИНГИБИРОВАНИЕ ВЗАИМОДЕЙСТВИЯ caPCNA ПРИ РАКЕ |
| WO2008036929A2 (en) * | 2006-09-21 | 2008-03-27 | Alnylam Pharmaceuticals, Inc. | Complex for transferring an anionic substance into a cell |
| GB0803352D0 (en) | 2008-02-22 | 2008-04-02 | Ntnu Technology Transfer As | Oligopeptidic compounds and uses thereof |
| CA2732737C (en) * | 2008-07-24 | 2019-03-05 | Indiana University Research And Technology Corporation | Cancer peptide therapeutics |
| FR2942798B1 (fr) * | 2009-03-05 | 2011-04-08 | Centre Nat Rech Scient | Peptides utilisables pour le traitement de la leucemie lymphoide chronique |
| WO2011044374A1 (en) * | 2009-10-07 | 2011-04-14 | Indiana University Research And Technology Corporation | Capcna peptide therapeutics for cancer |
| EP2538959A1 (en) * | 2010-02-24 | 2013-01-02 | Institut National de la Santé et de la Recherche Médicale | Compounds for the treatment of inflammation and neutropenia |
| JP2013522613A (ja) * | 2010-03-18 | 2013-06-13 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 化学療法に対する応答性を予測するための方法 |
| US9475840B2 (en) | 2012-02-27 | 2016-10-25 | Universitat De Barcelona | Protease-resistant compounds useful as shuttles through the blood-brain barrier and shuttle-cargo constructs |
| GB201214007D0 (en) * | 2012-08-07 | 2012-09-19 | Scancell Ltd | Anti-tumour immune responses to modified self-epitopes |
| US10420840B2 (en) * | 2015-04-10 | 2019-09-24 | Rll, Llc | Anticancer therapeutic agents |
| JP2020514256A (ja) * | 2016-12-15 | 2020-05-21 | ザ ナショナル インスティチュート フォー バイオテクノロジー イン ザ ネゲヴ,リミテッド | 抗pcnaモノクローナル抗体及びその使用 |
| GB201815041D0 (en) | 2018-09-14 | 2018-10-31 | Scancell Ltd | Epitopes |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5935797A (en) | 1994-06-16 | 1999-08-10 | Stanford University | Interaction of MHC Class II proteins with members of the PCNA family of proteins |
| GB9509557D0 (en) * | 1995-05-11 | 1995-07-05 | Univ Dundee | PCNA binding substance |
| JP2002518341A (ja) * | 1998-06-15 | 2002-06-25 | アーチ・デヴェロップメント・コーポレイション | 放射線療法と抗血管形成因子の組み合わせ |
| US7294471B2 (en) | 2002-02-27 | 2007-11-13 | Cskeys, Llc | Method for purifying cancer-specific proliferating cell nuclear antigen |
| MX2007013584A (es) | 2005-04-27 | 2008-04-22 | Univ Indiana Res & Tech Corp | Anticuerpos de isoforma de cspcna y sus usos. |
| DE602006021178D1 (de) | 2005-06-27 | 2011-05-19 | Univ Indiana Res & Tech Corp | Cspcna-isoform-modifikationen und anwendungen davon |
| EA200801847A1 (ru) * | 2006-02-17 | 2009-02-27 | Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн | ПЕПТИДНОЕ ИНГИБИРОВАНИЕ ВЗАИМОДЕЙСТВИЯ caPCNA ПРИ РАКЕ |
-
2007
- 2007-02-16 EA EA200801847A patent/EA200801847A1/ru unknown
- 2007-02-16 CA CA2638866A patent/CA2638866C/en active Active
- 2007-02-16 AU AU2007217037A patent/AU2007217037A1/en not_active Abandoned
- 2007-02-16 CN CNA2007800052894A patent/CN101384618A/zh active Pending
- 2007-02-16 JP JP2008555524A patent/JP2009527498A/ja active Pending
- 2007-02-16 BR BRPI0707948-6A patent/BRPI0707948A2/pt not_active Application Discontinuation
- 2007-02-16 EP EP07757135A patent/EP1989225A2/en not_active Withdrawn
- 2007-02-16 WO PCT/US2007/062335 patent/WO2007098415A2/en not_active Ceased
- 2007-02-16 US US12/279,028 patent/US8653039B2/en active Active
-
2014
- 2014-02-18 US US14/182,550 patent/US9187526B2/en active Active
-
2015
- 2015-10-29 US US14/926,904 patent/US20160304559A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US9187526B2 (en) | 2015-11-17 |
| EP1989225A2 (en) | 2008-11-12 |
| CN101384618A (zh) | 2009-03-11 |
| BRPI0707948A2 (pt) | 2011-05-17 |
| US20140296156A1 (en) | 2014-10-02 |
| US20090232882A1 (en) | 2009-09-17 |
| CA2638866A1 (en) | 2007-08-30 |
| US20160304559A1 (en) | 2016-10-20 |
| WO2007098415A3 (en) | 2007-12-13 |
| US8653039B2 (en) | 2014-02-18 |
| AU2007217037A1 (en) | 2007-08-30 |
| WO2007098415A2 (en) | 2007-08-30 |
| CA2638866C (en) | 2015-11-10 |
| JP2009527498A (ja) | 2009-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007098415A3 (en) | Peptide based inhibition of capcna protein-protein interactions in cancer | |
| EP2536821A4 (en) | IMPROVING THE EFFECT OF FE-S-BUNDLE REQUIRING PROTEINS | |
| CL2011000086A1 (es) | Anticuerpo aislado o proteina funcional contra el polipeptido baffr que inhibe la proliferacion de celulas b; secuencia nucleotidicas de dicho anticuerpo; vector y celula huesped que comprende dicha secuencia; y su uso para tratar enfermedades autoinmunes o neoplasias de celulas b. | |
| EA201690377A1 (ru) | Антитела к ингибитору активатора плазминогена 1 (pai-1) и пути их применения | |
| WO2010011890A3 (en) | Cancer peptide therapeutics | |
| EA202090805A1 (ru) | Клетки для получения рекомбинантной идуронат-2-сульфатазы | |
| AU2010220421A8 (en) | Antibodies against a proliferating inducing ligand (APRIL) | |
| NZ595707A (en) | Cancer antigen helper peptide | |
| MX351502B (es) | Anticuerpos de union de albumina y fragmentos de union de los mismos. | |
| EA200800229A1 (ru) | Человеческие моноклональные антитела против лиганда-1 запрограммированной гибели клеток (pd-l1) | |
| EA201301180A1 (ru) | Основанная на bcma стратификация и терапия пациентов, страдающих множественной миеломой | |
| CA2848209C (en) | T cell receptors recognizing hla-a1- or hla-cw7-restricted mage | |
| AR068553A1 (es) | Vacunas y componentes de vacuna para la inhibicion de celulas microbianas | |
| EA201100779A1 (ru) | Композиции антител к cxcr1 и способы их применения | |
| ECSP099341A (es) | Nuevos anticuerpos antiproliferativos | |
| AU2011353197A8 (en) | A cross linking polypeptide comprising an hexameric single chain antibody binding MHC-MAGE complex that induces apoptosis | |
| NO20081987L (no) | Humane, monoklonale antistoffer mot CD70 | |
| MX2014005108A (es) | Constructos de polipeptidos y sus usos. | |
| MX384246B (es) | POLIPÉPTIDO DE UNIÓN A TCR ALFA BETA PARA USARSE EN LA DISMINUCIÓN DE LINFOCITOS TAß. | |
| CY1121466T1 (el) | Αντισωματα εναντι προσδεματων υποδοχεα β1 βραδυκινινης | |
| MX348152B (es) | Anticuerpo monoclonal humano con especificidad para el virus del dengue serotipo 1 proteina e y sus usos. | |
| NZ601582A (en) | Agonist dr5 binding polypeptides | |
| EA201991409A3 (ru) | Антитела к ингибитору активатора плазминогена 1 (pai-1) и пути их применения | |
| ATE404225T1 (de) | Radiofluorierte peptide | |
| IL189452A0 (en) | Therapy with cd4 binding peptides and radiation |